What exactly happens in the hearts of patients with heart failure with preserved ejection fraction (HFpEF)—and how can this ...

U.S. Launch of MYQORZO® (aficamten) in Late January Met with Strong Demand; Over 275 HCPs Prescribed MYQORZO to an estimated 680 Patients in ...

Data Trends provide quick, visually memorable data-driven information and insights that are useful in clinical practice.

Recent data underscores the need for improved primary care detection of heart failure with preserved ejection fraction.

NVO heads into Q1 with strong GLP-1 drug demand and new Wegovy pill rollout, but pricing pressure, weak guidance and Eli ...

Tim is a transformational commercial leader with a proven ability to translate complex science into successful product launches,” said Chris Giordano, President and Chief Executive Officer of Tenax ...

aDepartment of Cardiovascular Sciences, University of Leicester, United Kingdom bNIHR Leicester Biomedical Research Centre –Cardiology, Department of Cardiovascular Sciences, College of Life Sciences, ...

A new study from Temple University and Cedars-Sinai has revealed that mitochondrial remodeling and metabolic disruptions are key contributors to heart failure with preserved ejection fraction (HFpEF).

This month’s list features a tribute to Eugene Braunwald, dyslipidemia guidelines, abundant news from ACC, and more.

Can weight loss reverse heart failure? A new study shows that heart muscle cells regain strength and muscle contractions ...

A new study suggests severe obesity may weaken heart muscle cells in people with heart failure with preserved ejection ...

Mr. Staab has over 25 years of financial and executive experience across the healthcare industry CHAPEL HILL, N.C., April 22, ...